2044 NEW ZEALAND GAZETTE, No. 86 2 JUNE 2005

Product:
MDS QuickPeak + Plus Ovulation Predictor Kit

Active Ingredients:
Bovine serum albumin 0.7µg
Goat anti-alpha-hCG polyclonal antibody 1.4µg
Goat anti-mouse polyclonal antibody 3.5µg
Murine anti-beta-hCG monoclonal antibody-colloidal gold conjugate 1.4µg

Dosage Form:
Pregnancy test kit

New Zealand Sponsor:
MDS Diagnostics Limited

Manufacturer:
Phamatech, San Diego, California, United States of America

Dated this 27th day of May 2005.

BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3386

New Zealand Public Health and Disability Act 2000

Reappointment/appointments to the Health Workforce Advisory Committee

Pursuant to section 12 of the New Zealand Public Health and Disability Act 2000, I reappoint

Professor Colin Mantell
to the Health Workforce Advisory Committee for a two-year term of office commencing from the date of this notification;
and I appoint

Dr Jim Vause

Professor Frances Hughes
Annamaria Muller-Matthews
Suzanne Win

to the Health Workforce Advisory Committee for a three-year term of office commencing from the date of this notification;
and also I appoint

Dr Clive Ross

as deputy chair of the Health Workforce Advisory Committee commencing from the date of this notification and expiring in March 2007.

Dated at Wellington this 30th day of May 2005.

ANNETTE KING, Minister of Health.

go3444

Social Security Act 1964

Formal Policy Statement for the Residential Care Loan Scheme (Effective From 1 July 2005)

Pursuant to section 153 of the Social Security Act 1964, that provides statutory recognition and specification of the residential care loan scheme, the Director-General of Health has approved the following formal policy statement for the Residential Care Loan Scheme (effective from 1 July 2005).

What is a residential care loan?

1. It is an agreement between the Crown and a borrower ("client") under which the Crown advances funds to a provider, on the client’s behalf, for any contracted care services received by the client.

2. Generally, a residential care loan ("loan") is secured over the client’s former home, with the Crown’s interest being protected by a caveat lodged against the title to the former home.

3. The loan is generally due to be repaid when the client dies or the former home is sold or otherwise disposed of, whichever happens earlier.

Legal basis for the loan scheme

4. Section 153 of the Social Security Act 1964 ("the Act") provides statutory recognition and specification of the residential care loan scheme ("the loan scheme"):

"153 Residential care loan scheme
A person who has been means assessed as to assets may apply for a loan under the residential care loan scheme operated by the Ministry of Health if:

(a) the person’s assets are above the applicable asset threshold; and

(b) the person meets the criteria for eligibility for the residential care loan scheme as notified by the Director-General of Health in the Gazette."

Roles and responsibilities

5. The Ministry of Health is responsible for the loan scheme policy, funding residential care under the loan scheme, and issuing loan statements to clients. The Ministry of Social Development administers the loan scheme as an agent of the Ministry of Health through a Power of Attorney, and provides certain legal and administrative services in relation to the loan scheme. All references to the Ministry of Social Development in this policy are as agent for the Ministry of Health.

Glossary

6. All terms used in this policy have the same meanings as in Part 4 and Schedule 27 of the Act. In addition, in this policy: